Cyclops®
Pre-filled
dry Powder inhaler
![](https://pureims.com/wp-content/uploads/sites/3/2019/09/cyclops-orange-2.png)
Cyclops® is a state-of-the-art, easy to use, pre-filled DPI that is developed by PureIMS for inhalation powders.
Because of its simple yet
sophisticated proprietary design it can be produced in a cost-effective way.
Cyclops® is available in single & multi use versions.
Upon inhalation it uses the patient’s breath to disperse the dry powder formulation into small particles appropriately sized for deep lung deposition. Cyclops® has several advantages compared to standard-of-care DPIs across key therapeutic areas. These attributes enable the hygienic and effective use on a worldwide scale. One product, Colistin Cyclops®, is already available to patients and reimbursed under a named patient regimen for the treatment of cystic fibrosis.
HIGHLY PREFERRED BY PATIENTS
LATEST NEWS
![](https://pureims.com/wp-content/uploads/sites/3/2024/05/Picture1.png)
Cyclops® in Inhalation Technology magazine!
Dry powder inhalers for rescue applications Check out this fascinating
May 28, 2024
![](https://pureims.com/wp-content/uploads/sites/3/2024/05/IAPRD2024-poster_Hoppentocht_website.jpg)
IAPRD poster on Levodopa Cyclops®
Check out our scientific poster on Levodopa Cyclops® for the
May 14, 2024
![](https://pureims.com/wp-content/uploads/sites/3/2024/01/parkinsons-press-relase-picture_crop-768x520.png)
PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study
Roden, the Netherlands, January 18, 2024 PureIMS, a pharmaceutical company
January 18, 2024
![](https://pureims.com/wp-content/uploads/sites/3/2023/09/Winnaar-Innovation-Award-_PURE-IMS-8-min_k-768x512.jpg)
PureIMS winning the LIFE Science Innovation Award!
Tuesday September 26 was an exciting day for the PureIMS team. Not
September 27, 2023
![](https://pureims.com/wp-content/uploads/sites/3/2023/08/Foto-Levodopa-Cyclops-start-study-1-768x519.jpg)
PureIMS initiates dose-finding study with Levodopa Cyclops™ dry powder inhaler
Following a successful funding round in April of this year
August 23, 2023